GlassScriptPhysician profile
Mary A Endicott
NPI 1831482355
$544.41
in general payments reported to CMS, 2019-2025
16 companies · $49.54 in 2025
The $49.54 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $60.65 · 2023: $154 · 2024: $113 · 2025: $49.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.69 | 2021-2025 | Wegovy |
| Smith+Nephew, INC. | $60.83 | 2021-2025 | Collagenase Santyl |
| Davol INC. | $50.47 | 2023-2024 | Arista Ah Flexitip |
| Baxter Healthcare | $46.24 | 2021-2023 | Peri-Strips Dry |
| Kowa Pharmaceuticals America, INC. | $42.01 | 2022 | |
| Mozarc Medical US LLC | $36.46 | 2024 | Argyle |
| Kci USA, INC. | $23.37 | 2023 | Prevena, V.A.C. Veraflo |
| Teleflex LLC | $20.43 | 2024 | Deknatel |
| Integra Lifesciences Corporation | $19.63 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $17.84 | 2021 | |
| Endo Pharmaceuticals INC. | $17.04 | 2023 | Nascobal |
| Lilly USA, LLC | $16.77 | 2023 | Zepbound, Jardiance |
| Abbott Laboratories | $13.35 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.32 | 2021 | |
| Bard Peripheral Vascular, INC. | $12.50 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Endicott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.